- Heterogeneity and temporal variation in the management of COVID-19: A multinational drug utilisation study including 274,719 hospitalised patients from, the United States of America, China, Spain, and South KoreaPrats-Uribe, Albert; Sena, Anthony G.; Lai, Lana Yin Hui; Ahmed, Waheed-Ul-Rahman; Alghoul, Heba; Alser, Osaid; Alshammari, Thamir M.; Areia, Carlos; Carter, William A.; Casajust, Paula; Dawoud, Dalia; Golozar, Asieh; Jonnagaddala, Jitendra; Mehta, Paras; Mengchun, Gong; Morales, Daniel R.; Nyberg, Fredrik; Posada, Jose D.; Recalde, Martina; Roel, Elena; Shah, Karishma; Shah, Nigam H.; Schilling, Lisa M.; Subbian, Vignesh; Vizcaya, David; Zhang, Lin; Zhang, Ying; Zhu, Hong; Liu, Li
- Impact of COVID-19 pandemic restrictions on primary care for neurological disorders in the United KingdomJohnson, Kyle; Beradid, Sarah; Renoux, Christel26th World Congress of Neurology (WCN), Montreal, CANADA, 2023-10-15 To 2023-10-19.
- The impact of COVID-19 on doses of medications for Parkinson's disease after 24 months: CovPark-LTLokominiene, Ruta Kaladyte; Lokominaite, Gabriele26th World Congress of Neurology (WCN), Montreal, CANADA, 2023-10-15 To 2023-10-19.
期刊论文
Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak
5阅读
